Table 2.
Histomorphometric analysis. Tissues evaluated in the various regions after 8 weeks of healing
| Antrostomy | Sinus regions | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Edges | Center | Total | Close-to-window | Middle | Sub-mucosa | Bone walls | Total | ||
| New bone | Treated sites |
40.3 ± 21.3 37.8 (27.0;56.0) |
24.3 ± 23.2 22.0 (3.4;42.2) |
35.5 ± 20.9 27.7 (23.3;52.0) |
25.8* ± 16.1 22.9 (15.2;39.7) |
19.5 ± 16.7 11.7 (10.1;22.3) |
22.5 ± 11.6 20.4 (12.6;31.3) |
38.0 ± 15.0 44.8 (31.8;47.5) |
27.9 ± 12.9 30.1 (19.6;34.5) |
| Untreated sites |
32.2 ± 22.3 33.0 (12.5;44.9) |
20.5 ± 30.2 10.7 (0.0;24.6) |
28.6 ± 24.1 25.7 (8.8;39.4) |
17.6* ± 16.3 21.8 (3.0;25.8) |
18.2 ± 21.4 5.7 (2.1;31.1) |
19.1 ± 13.5 13.1 (12.3;27.8) |
35.4 ± 15.0 38.3 (24.0;44.4) |
23.6 ± 15.2 22.6 (11.8;34.2) |
|
| Xenograft | Treated sites |
3.3 ± 5.8 0.0 (0.0;3.9) |
3.6* ± 5.0 0.0 (0.0;6.7) |
3.4 ± 4.9 0.0 (0.0;5.6) |
15.5 ± 14.4 15.4 (2.1;27.5) |
18.8 ± 11.3 20.8 (11.8;26.1) |
21.1 ± 9.9 20.2 (18.3;24.6) |
13.1 ± 17.1 5.2 (2.4;19.9) |
17.2 ± 12.0 12.6 (10.4;25.9) |
| Untreated sites |
10.5 ± 12.4 4.5 (1.6;15.8) |
14.6* ± 16.5 9.3 (2.6;20.5) |
11.8 ± 13.0 10.0 (1.7;15.6) |
15.5 ± 14.2 16.1 (4.5;22.9) |
23.4 ± 18.2 31.2 (5.4;37.8) |
22.1 ± 12.9 26.7 (10.1;29.8) |
9.6 ± 8.1 9.4 (2.4;16.1) |
17.4 ± 12.3 20.7 (5.8; 27.8) |
|
| Soft tissue | Treated sites |
56.4 ± 16.2 59.3 (48.5;65.8) |
72.1 ± 19.6 69.0 (60.4;91.8) |
61.1 ± 15.8 65.6 (51.9;72.0) |
58.7 ± 7.2 58.3 (54.4;61.5) |
61.7 ± 11.5 58.8 (57.4;64.6) |
56.5 ± 7.5 56.6 (52.5;58.8) |
49.0 ± 16.7 51.9 (47.7;55.2) |
55.0 ± 8.1 55.2 (51.9;58.3) |
| Untreated sites |
57.3 ± 15.6 55.4 (53.8;59.6) |
64.9 ± 22.5 68.5 (62.0;77.8) |
59.6 ± 16.6 59.3 (56.0;64.5) |
66.9 ± 11.8 69.1 (59.2;73.7) |
58.4 ± 9.3 61.0 (54.8;65.3) |
58.8 ± 3.3 59.2 (58.1;61.3) |
55.0 ± 8.4 57.0 (52.0;59.8) |
59.0 ± 5.9 58.8 (57.7;60.4) |
|
Data in percentages. Mean values in italics ± standard deviations. Medians (25th; 75th) percentiles. *p < 0.05